Rona Therapeutics｜Innovative siRNA Medicines & RNA Therapeutics Platform

Rona Therapeutics Participated in the 2023 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) and Published Novel ApoC3 siRNA Preclinical Results

Rona Therapeutics's First Self-developed siRNA Product has been Approved for Conducting Clinical Trial in China

Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis



Jinyu Huang, Ph.D.

Chief Executive Officer, Founder

Stella Shi is founder, Chief Executive Officer and chairs the board of Rona Therapeutics since company inception in 2021 bringing ~15 years of biopharmaceutical industry and venture capital experience. Prior to founding Rona Therapeutics, Stella was managing director in Lilly Asia Ventures (LAV) from 2015 with proven track records with various venture creation ...